Elucigene Diagnostics, Lifecodexx Partner
News Oct 27, 2016
Elucigene Diagnostics and LifeCodexx AG announced that they have partnered with the aim of providing access for UK and Irish patients to LifeCodexx’ proprietary PrenaTest® NIPT technology.
PrenaTest® was Europe’s first non-invasive prenatal test (NIPT), significantly enhancing prenatal trisomy screening sensitivity, whilst drastically reducing invasive procedure linked pregnancy loss occurrence. The test is performed within Germany in strict conformity with the highest quality standards as per the European Directive on In-vitro Diagnostic Medical Devices. Currently, every 30 minutes a pregnant woman opts for PrenaTest® being a leading NIPT across Europe and the Middle East.
Dr. Mark Street-Docherty, Commercial Manager of Elucigene Diagnostics says “We are delighted to be able to offer pregnant women across the UK access to leading NIPT technology, ensuring safe and accurate screening for the most common chromosomal trisomies. This service complements our continued support for prenatal testing accuracy, alongside our leading QST*R diagnostic prenatal range”.
“We are very pleased to add Elucigene Diagnostics to our group of partners with their long standing expertise in the field of prenatal diagnostic in the U.K but also elsewhere,” added Dr. Michael Lutz, CEO of LifeCodexx. “With this new partnership, our high quality PrenaTest® is now available in more than 40 countries throughout Europe and the Middle East.”
"Cell Quake Elastography" Maps Elasticity of Cell ComponentsNews
In somewhat the same way that seismologists use the vibrations of planet Earth to characterize its deep structure, scientists have discovered a way to use vibrations within cells to identify their mechanical properties.READ MORE
Tweak to Technique Could Bolster Disease DetectionNews
A team of Stanford researchers has developed a technique that they hope could more precisely detect diseases or disorders such as cancer or a heart attack.READ MORE
Diagnosing Immunity to Ebola With Paper Tests & SmartphonesNews
A promising new approach to detect immunity to Ebola virus infection has been developed by researchers from i-sense in a collaboration between UCL and Imperial College London.READ MORE
Comments | 0 ADD COMMENT
Precision Medicine & Biomarkers Leaders Summit: USA
May 07 - May 08, 2018